We invite you to explore the following top five papers published in 2024 in the “Radiopharmaceutical Sciences” Section:
1. “Alpha-Emitting Radionuclides: Current Status and Future Perspectives”
by Matthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, David Kästner, Marc Pretze, Enrico Michler, Claudia Brogsitter, Jörg Kotzerke, Klaus Kopka, David A. Scheinberg et al.
Pharmaceuticals 2024, 17(1), 76; https://doi.org/10.3390/ph17010076
Available online: https://www.mdpi.com/1424-8247/17/1/76
2. “Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands”
by Kim E. de Roode, Lieke Joosten and Martin Behe
Pharmaceuticals 2024, 17(2), 256; https://doi.org/10.3390/ph17020256
Available online: https://www.mdpi.com/1424-8247/17/2/256
3. “Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy”
by Jeremy P. McGale, Harrison J. Howell, Arnaud Beddok, Mickael Tordjman, Roger Sun, Delphine Chen, Anna M. Wu, Tarek Assi, Samy Ammari and Laurent Dercle
Pharmaceuticals 2024, 17(2), 210; https://doi.org/10.3390/ph17020210
Available online: https://www.mdpi.com/1424-8247/17/2/210
4. “Functionalization of 68Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities”
by Thomas Wanek, Marco Raabe, Md Noor A Alam, Thomas Filip, Johann Stanek, Mathilde Loebsch, Christian Laube, Severin Mairinger, Tanja Weil and Claudia Kuntner
Pharmaceuticals 2024, 17(4), 514; https://doi.org/10.3390/ph17040514
Available online: https://www.mdpi.com/1424-8247/17/4/514
5. “Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate”
by Falguni Basuli, Olga Vasalatiy, Jianfeng Shi, Kelly C. Lane, Freddy E. Escorcia and Rolf E. Swenson
Pharmaceuticals 2024, 17(4), 480; https://doi.org/10.3390/ph17040480
Available online: https://www.mdpi.com/1424-8247/17/4/480
